Skip to main content
Menu
US
Cell Counting and Image Cytometry

Direct NK Cell Killing

Section
Celigo Applications
Celigo Applications
Cell Counting Method Selection
Cell Counting and Image Cytometry FAQs
Cell-based Assays for Bioprocessing
Cell-based Assays for Gene Therapy Development
Cellometer Applications
Modern Virology Assays
Sub Section
Celigo Image Cytometer Direct Cell Counting Assays for Immunotherapy
3D Cell Models
Assays for Virology Research
Brightfield Applications
Celigo Cell Counting Applications
Celigo Fluorescent Assays
Celigo Image Cytometer Direct Cell Counting Assays for Immunotherapy
Cell Line Development
Migration and Invasion Assays
iPSC Reprogramming
Topic
Direct NK Cell Killing
Complement-Dependent Cytotoxicity
Antibody-dependent Cell-mediated Cytotoxicity
CAR-T Mediated Toxicity
Direct NK Cell Killing
Obtaining a Direct Cell Count
Using The Gating Interface
Whole Well Imaging

Quantification of natural killer cell-mediated cytotoxicity

  1. Determination of percent cell lysis of target cells
  2. Flexibility to use NK cells that are purified or in PBMCs
  3. Production of BF and FL images of direct target cell killing by NK-cells

Non-toxic Calcein AM release assay for direct NK cell killing

Typical NK cell-mediated killing involves accessory signaling or interactions in order to induce NK cell activation and downstream cytotoxicity. NK-cells can be activated by antigen presenting cells and/or multiple cytokines.

Activation of NK cells by pathogens

To examine direct NK cell-killing, there are two methods:

  1. The purified NK cells are genetically engineered to identify, bind to and kill target tumor cells.
  2. Human PBMCs containing NK cells are further stimulated with IL-2 to induce a more robust activation and promote target cell killing.

Traditionally, cytotoxicity assays have been performed using Chromium-51 release, LDH release, Luciferase Reporter Assay and fluorescent release assays (described below).

Detection method Description Existing issues
Radioactivity release Measure the release of radiolabels, 51Cr, 101In in the supernatant Handling hazardous material.
Indirect measurement of cell death
Fluorescence release Measure the release of Calcein AM fluorescent molecules in the supernatant Indirect measurement of cell death
Endpoint assay only
LDH release Measure the release of cytosolic enzyme in the supernatant Indirect measurement of cell death
Endpoint assay only
Luciferase reporter assay Measure luciferase as the cells die Indirect measurement of cell death
Flow cytometry Measure the number of viable cells and viability in the sample Cannot be performed in plates
Must trypsinize for adherent cells


Alternatively, by labeling the target tumor cells with non-toxic, non-radioactive Calcein AM, we can monitor the killing of the tumor cells by the immune effector cells by performing a Calcein AM release assay.

Quantification of natural killer cell-mediated cytotoxicity

Celigo image cytometer experimental protocol

  • IMR32 (adherent) and K562 (suspension) target cells were used to demonstrate the NK cell-mediated cytotoxicity detection method using Calcein AM staining for direct cell counting
  • Target cells (adherent and suspension) were collected and stained with Calcein AM
  • Target cells were seeded in 96-well microplates
  • Effector cells were added to the wells at different Effector (E):Target (T) ratios (10:1, 5:1, 2.5:1, 1.3:1, 0.6:1, and 0.3:1)
  • The wells were scanned and analyzed using Celigo for direct cell counting Calcein AM-stained target cells
  • Cells at different E:T ratios were imaged at 4 hours after adding effector cells to target cells
  • A time-course (t = 1 – 4 hours) was performed to determine percent cytotoxicity by monitoring the reduction in Calcein AM-stained target cells
  • The maximum release control uses Triton X100 to lyse all cells and release the Calcein AM fluorescent molecules
Experiment Plate Map NK

Experiment plate map

Two target cell lines, IMR32 and K562 were prepared. Effector NK-cells were added at different E:T ratios.


E:T Ratio and Time-Dependent Cytotoxicity of K562 and IMR32

Cytotoxicity of K562 and IMR32

Representative 4 hour brightfield and Calcein AM overlay images showing E:T ratio dependent cell killing. Calcein AM-labeled target cells are not killed in the control image, while nearly all of the target cells are killed in the 5:1 effector to target cell sample.

Calculating the percentage cell lysis

Percent cell lysis flow chart

% Lysis calculation for cytotoxicity measurement

  • Count # of live target cells (Calcein AM positive) in wells with effector cells
  • Count # of live target cells (Calcein AM positive) in wells without effector cells (control)
Precent lysis equation

E:T Ratio dependent NK cell-mediated cytotoxicity (Stained K562 cell imaged at t = 4 hr)

K562 cells stained with calcein AM-1

The example Calcein+ fluorescent images are the K562 target cells at t = 4 hours

The resulting fluorescent images showed an increase in Calcein AM-positive target cells as E:T ratio decreased

E:T Ratio dependent NK cell-mediated cytotoxicity results

Percent lysis plots target cells

The percent lysis is plotted to show the effect of E:T ratios on target IMR32 and K562 cells. Live adherent IMR32 cells were directly measured using the Celigo instrument without trypsinization. The number of Calcein AM positive cells at t = 4 hrs was used to calculate the percent lysis for each E:T ratio.

Time-dependent NK cell-mediated cytotoxicity (NK cell: K562 cell ratio (E:T) = 2.5:1)

NK Cell-Mediated Cytotoxicity

Live K562 suspension cells were directly measured using the Celigo image cytometer. The number of Calcein AM-positive cells was counted at each hour and used to calculate the percent lysis for each E:T ratio

Time-dependent NK cell-mediated cytotoxicity results

Percent lysis plots

The percent lysis is plotted to show the effect of E:T ratios on target IMR32 and K562 cells. Live adherent IMR32 cells were directly measured using the Celigo image cytometer without trypsinization. The number of Calcein AM-positive cells was counted at each hour and obtained cell numbers were used to calculate the percent lysis for each E:T ratio. By analyzing the time course data of IMR32, we can see that there is a large percent lysis difference between the E:T ratios.

Cytotoxicity assay using IL-2 stimulated NK Cells in a patient-donated PBMC sample

Celigo image cytometer experimental protocol

  • The target cells (K562) were stained with 5 µM Calcein AM for 30 min
  • The target cells were then seeded into the 96-well plate at 10,000 cells/well
  • Next, the effector cells were added following the E:T ratios shown on the plate map (below)
  • Finally, IL-2 was added to half of the wells to activate NK cells
  • The spontaneous release was seen in K562-stained cell without PBMCs
  • Maximum release was seen in stained target cells that were treated with a lysing agent
  • After adding the cells and IL-2, the plate was centrifuged in order to settle the cells to the bottom of the plate
  • Immediately after, the plate was scanned using the Celigo image cytometer
  • The scans were acquired at T = 1, 2, 3, and 4 hr
Patient donated PBMC samples

Calculating the percentage cell lysis

The counted number of Calcein AM positive target cells with and without effector cells

The counted number of Calcein AM positive target cells with and without IL2

Normalize to t = 0 

Percent lysis equation normalize t 0

1. Normalize to spontaneous release

Percent lysis final equation

1. The %Lysis is calculated for every well and averaged to generate dose response and time course monitoring

Cytotoxicity dose response

Cytotoxicity dose response graph

A greater percent lysis was observed in samples at a high E:T ratio with IL-2. Overall, even at lower E:T ratios, the percent lysis was greater in samples containing IL-2.

Time course monitoring

Time Course Monitoring

Percent lysis was observed above the target only control for all samples. Donor samples with IL-2 showed a greater percent lysis compared to the no IL-2 samples.


For research use only. Not for use in diagnostic procedures.

ON THIS PAGE